"Symeonidou V"[Author] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
2020	1
2021	2
2022	1
2024	0

Page 1

Defining the fetal origin of MLL-AF4 infant leukemia highlights specific fatty acid requirements.

Symeonidou V, Jakobczyk H, Bashanfer S, Malouf C, Fotopoulou F, Kotecha RS, Anderson RA, Finch AJ, Ottersbach K. Symeonidou V, et al. Cell Rep. 2021 Oct 26;37(4):109900. doi: 10.1016/j.celrep.2021.109900. Cell Rep. 2021. PMID: 34706236 Free PMC article.

Heterogeneous genetic and non-genetic mechanisms contribute to response and resistance to azacitidine monotherapy.

Symeonidou V, Metzner M, Usukhbayar B, Jackson AE, Fox S, Craddock CF, Vyas P. Symeonidou V, et al. EJHaem. 2022 Jul 8;3(3):794-803. doi: 10.1002/jha2.527. eCollection 2022 Aug. EJHaem. 2022. PMID: 36051087 Free PMC article.

HOXA9/IRX1 expression pattern defines two subgroups of infant MLL-AF4-driven acute lymphoblastic leukemia.

Symeonidou V, Ottersbach K. Symeonidou V, et al. Exp Hematol. 2021 Jan;93:38-43.e5. doi: 10.1016/j.exphem.2020.10.002. Epub 2020 Oct 15. Exp Hematol. 2021. PMID: 33069783 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year